Adriana N Brewer, NP
Nurse Practitioner · Tehachapi
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Dignity Health Medical Foundation · 1,211 clinicians in this group
Looking this up.
Hospitals listed: 557094 · Adventist Health Bakersfield · Adventist Health Tehachapi Valley. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Adriana N Brewer’s office at (661) 822-2530 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health BakersfieldBakersfield, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.146, Oct 2024 – Sep 2025
- Adventist Health Tehachapi ValleyTehachapi, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 5 of 5 · 88% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Adventist Health Bakersfield
Behind the star rating — Deaths: 0 better, 5 the same, 2 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.146 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.08 (0.1 to 2.06) · 1,228 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.48 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.57 (143.33 to 237.81) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.1 · 308 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.7 · 462 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.8 · 387 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 3,695 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.36) · 5,306 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 5,505 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.32 (1.18 to 5.46) · 1,081 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.99 (0.32 to 3.66) · 215 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.39 (0.84 to 3.93) · 1,043 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.06 (0 to 16.24) · 219 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.3 (1.28 to 9.31) · 212 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 263 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.15 (0 to 0.81) · 4,389 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 87 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.306 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.102 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.409 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.699 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 452 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 730 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 14 · 235 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -2 · 367 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.1 · 504 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 920 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4.5 to 8.7) · 216 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.6 to 14.7) · 216 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 67 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.9 to 17.8) · 170 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 406 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,099 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Adventist Health Tehachapi Valley
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 1 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 11.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.9 · 133 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 295 cases | None | Jul 2024 – Jun 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.625 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 63 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 23.8 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 8.4 · 136 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 172 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.1 (10.5 to 19.1) · 204 cases | No different | Jan 2022 – Dec 2024 |
What patients said (163 patients answered, 18% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 89% |
| Nurses "always" communicated well | 87% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 69% |
| Yes, staff "did" give patients this information | 93% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 85% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 83% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 88% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 95% |
Original Medicare doctor bills
$45,541
Medicare paid this office $45,541 for 235 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 126 | $12,215 | $55 |
| Return visit (30+ min) | 86 | $10,335 | $78 |
| New patient visit (45+ min) | 33 | $2,954 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $2,695 | $112 |
| New patient visit (30+ min) | 52 | $2,008 | $39 |
See all 14 services
| Short return visit (20+ min) | 126 | $12,215 | $55 |
| Return visit (30+ min) | 86 | $10,335 | $78 |
| New patient visit (45+ min) | 33 | $2,954 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $2,695 | $112 |
| New patient visit (30+ min) | 52 | $2,008 | $39 |
| Influenza vaccine, inactivated | 17 | $1,309 | $77 |
| Short return visit | 38 | $1,267 | $28 |
| Telephone medical discussion with physician, 5-10 minutes | 29 | $933 | $30 |
| Administration of influenza virus vaccine | 22 | $746 | $32 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $533 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $178 | $8 |
| Injection of drug or substance under skin or into muscle | 15 | $170 | $9 |
| Urinalysis, manual test | 15 | $65 | $3 |
| Assessment of emotional or behavioral problems | 13 | $43 | $3 |
Procedures Medicare counted
| Removal of skin lesions | 14 | More than 61% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
235 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 9% · Women 63% · Also on Medicaid 15% · Health risk score 1.04. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 68% · Coronary heart disease 26% · Diabetes 24% · Depression 19% · COPD 17% · Chronic kidney disease 14% · Atrial fibrillation 12% · Cancer 10% · Heart failure 9% · Dementia 5%.
The office billed $209,331, Medicare allowed $63,546 and paid $45,541; for 1,028 services of 49 kinds; $8,299 of it was for drugs given in the office and $37,241 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 235 | 1,028 | 73 | 1.04 | $209,331 | $45,541 |
| 2023 | 79 | 188 | 74 | 1.13 | $23,887 | $8,096 |
| 2022 | 45 | 89 | 71 | 1.13 | $6,507 | $3,828 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit | 46 | $2,264 | $35 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,580 | $113 |
| Return visit (30+ min) | 15 | $1,274 | $85 |
| Short return visit (20+ min) | 14 | $1,132 | $60 |
2022: 2 services
| Short return visit (20+ min) | 22 | $1,442 | $55 |
| Short return visit | 20 | $994 | $40 |
Drugs they prescribed that Part D paid
$362,340
Pharmacies billed $362,340 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (163 of 4,280) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
3,662 generic and 596 brand-name prescriptions · $362,340 in drug cost · 233 antibiotic prescriptions to 149 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 40 | $34,988 | $875 |
| Jardiance | 36 | $34,903 | $970 |
| Ozempic | 25 | $27,511 | $1,100 |
| Trelegy Ellipta | 21 | $16,337 | $778 |
| Linzess | 18 | $13,294 | $739 |
See all 97 drugs
| Eliquis | 40 | $34,988 | $875 |
| Jardiance | 36 | $34,903 | $970 |
| Ozempic | 25 | $27,511 | $1,100 |
| Trelegy Ellipta | 21 | $16,337 | $778 |
| Linzess | 18 | $13,294 | $739 |
| Breo Ellipta | 31 | $12,131 | $391 |
| Farxiga | 13 | $11,457 | $881 |
| Januvia | 14 | $11,408 | $815 |
| Celecoxib | 36 | $3,656 | $102 |
| Gabapentin | 106 | $2,711 | $26 |
| Esomeprazole Magnesium | 14 | $2,200 | $157 |
| Albuterol Sulfate Hfa | 87 | $1,986 | $23 |
| Levothyroxine | 137 | $1,594 | $12 |
| Atorvastatin | 183 | $1,464 | $8 |
| Buspirone | 35 | $1,124 | $32 |
| Hydrocodone-Acetaminophen | 81 | $970 | $12 |
| Diclofenac | 58 | $937 | $16 |
| Rosuvastatin | 53 | $915 | $17 |
| Tamsulosin | 62 | $901 | $15 |
| Losartan | 124 | $786 | $6 |
| Lisinopril | 141 | $755 | $5 |
| Ondansetron | 48 | $723 | $15 |
| Fluticasone-Salmeterol | 19 | $701 | $37 |
| Fluticasone Propionate | 38 | $685 | $18 |
| Synthroid | 23 | $671 | $29 |
| Levocetirizine Dihydrochloride | 16 | $661 | $41 |
| Potassium Chloride | 54 | $647 | $12 |
| Baclofen | 19 | $640 | $34 |
| Pregabalin | 26 | $623 | $24 |
| Lantus Solostar | 13 | $612 | $47 |
| Omeprazole | 55 | $581 | $11 |
| Nebivolol | 12 | $557 | $46 |
| Oxybutynin Chloride | 27 | $513 | $19 |
| Pantoprazole | 45 | $507 | $11 |
| Oxycodone-Acetaminophen | 27 | $497 | $18 |
| Oxybutynin Chloride Er | 15 | $490 | $33 |
| Duloxetine | 16 | $467 | $29 |
| Dicyclomine | 12 | $427 | $36 |
| Trazodone | 41 | $389 | $9 |
| Famotidine | 42 | $385 | $9 |
| Montelukast | 32 | $383 | $12 |
| Sodium Chloride | 38 | $378 | $10 |
| Ondansetron | 26 | $366 | $14 |
| Ezetimibe | 24 | $347 | $14 |
| Amlodipine Besylate | 89 | $341 | $4 |
| Meloxicam | 51 | $332 | $7 |
| Alendronate | 42 | $329 | $8 |
| Metoprolol | 25 | $314 | $13 |
| Amoxicillin-Clavulanate Potass | 54 | $308 | $6 |
| Pravastatin | 12 | $286 | $24 |
| Amitriptyline | 17 | $285 | $17 |
| Ciclopirox | 19 | $278 | $15 |
| Tizanidine | 38 | $266 | $7 |
| Methylprednisolone | 47 | $261 | $6 |
| Benazepril | 22 | $257 | $12 |
| Metformin | 59 | $253 | $4 |
| Butalbital-Acetaminophen-Caffe | 24 | $251 | $10 |
| Atenolol | 37 | $243 | $7 |
| Furosemide | 72 | $237 | $3 |
| Sertraline | 42 | $235 | $6 |
| Temazepam | 40 | $232 | $6 |
| Benztropine Mesylate | 12 | $222 | $19 |
| Ibuprofen | 29 | $218 | $8 |
| Clopidogrel | 31 | $206 | $7 |
| Simvastatin | 41 | $206 | $5 |
| Acetaminophen-Codeine | 15 | $186 | $12 |
| Doxycycline Hyclate | 25 | $184 | $7 |
| Nitrofurantoin Mono-Macro | 16 | $174 | $11 |
| Ropinirole | 16 | $167 | $10 |
| Zolpidem | 31 | $162 | $5 |
| Carvedilol | 24 | $155 | $6 |
| Tramadol | 36 | $153 | $4 |
| Hydroxyzine | 20 | $150 | $7 |
| Azithromycin | 51 | $145 | $3 |
| Clonidine | 45 | $144 | $3 |
| Lorazepam | 21 | $144 | $7 |
| Allopurinol | 13 | $136 | $10 |
| Escitalopram | 16 | $134 | $8 |
| Lisinopril-Hydrochlorothiazide | 15 | $132 | $9 |
| Hydrochlorothiazide | 47 | $131 | $3 |
| Hydralazine | 15 | $131 | $9 |
| Prednisone | 40 | $117 | $3 |
| Clonazepam | 19 | $114 | $6 |
| Alprazolam | 40 | $108 | $3 |
| Metoprolol | 41 | $103 | $3 |
| Glipizide | 21 | $93 | $4 |
| Terbinafine | 11 | $80 | $7 |
| Finasteride | 14 | $63 | $4 |
| Fluoxetine | 15 | $61 | $4 |
| Cephalexin | 18 | $58 | $3 |
| Fluconazole | 15 | $50 | $3 |
| Glimepiride | 11 | $49 | $4 |
| Sulfamethoxazole-Trimethoprim | 15 | $44 | $3 |
| Metformin Hcl Er | 12 | $40 | $3 |
| Amoxicillin | 20 | $33 | $2 |
| Ciprofloxacin | 15 | $31 | $2 |
| Diazepam | 19 | $26 | $1 |
Year by year
| 2024 | 4,280 | 629 | 4% (163) | 14% | $362,340 |
| 2023 | 4,412 | 689 | 4% (188) | 13% | $428,298 |
| 2022 | 1,090 | 305 | 6% (70) | 12% | $74,099 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 103 drugs
| Jardiance | 47 | $49,022 | $1,043 |
| Trulicity | 40 | $44,041 | $1,101 |
| Trelegy Ellipta | 23 | $30,555 | $1,328 |
| Eliquis | 34 | $26,420 | $777 |
| Januvia | 19 | $22,228 | $1,170 |
| Ozempic | 20 | $19,950 | $998 |
| Tradjenta | 22 | $14,431 | $656 |
| Symbicort | 29 | $13,217 | $456 |
| Xarelto | 15 | $11,322 | $755 |
| Spiriva Respimat | 14 | $7,911 | $565 |
| Myrbetriq | 14 | $7,409 | $529 |
| Linzess | 12 | $6,656 | $555 |
| Incruse Ellipta | 13 | $6,510 | $501 |
| Levemir | 12 | $4,108 | $342 |
| Qvar Redihaler | 13 | $4,006 | $308 |
| Levothyroxine | 150 | $3,080 | $21 |
| Hydrocodone-Acetaminophen | 105 | $2,971 | $28 |
| Atorvastatin | 258 | $2,947 | $11 |
| Albuterol Sulfate Hfa | 93 | $2,681 | $29 |
| Gabapentin | 113 | $2,320 | $21 |
| Fluticasone-Salmeterol | 12 | $2,004 | $167 |
| Tamsulosin | 68 | $1,933 | $28 |
| Losartan | 128 | $1,659 | $13 |
| Lisinopril | 169 | $1,326 | $8 |
| Ezetimibe | 11 | $1,122 | $102 |
| Diclofenac | 27 | $1,118 | $41 |
| Omeprazole | 91 | $1,070 | $12 |
| Fluticasone Propionate | 64 | $1,059 | $17 |
| Ketoconazole | 14 | $1,026 | $73 |
| Memantine | 17 | $996 | $59 |
| Pregabalin | 19 | $938 | $49 |
| Oxycodone-Acetaminophen | 24 | $868 | $36 |
| Metformin | 122 | $839 | $7 |
| Pantoprazole | 68 | $838 | $12 |
| Trazodone | 50 | $818 | $16 |
| Quetiapine | 24 | $791 | $33 |
| Levocetirizine Dihydrochloride | 22 | $784 | $36 |
| Amlodipine Besylate | 110 | $733 | $7 |
| Rosuvastatin | 44 | $682 | $16 |
| Clopidogrel | 35 | $651 | $19 |
| Potassium Chloride | 29 | $595 | $21 |
| Meloxicam | 55 | $586 | $11 |
| Acarbose | 17 | $555 | $33 |
| Metoprolol | 57 | $498 | $9 |
| Escitalopram | 34 | $490 | $14 |
| Buspirone | 28 | $482 | $17 |
| Zolpidem | 77 | $478 | $6 |
| Ondansetron | 18 | $456 | $25 |
| Alendronate | 39 | $452 | $12 |
| Ibuprofen | 47 | $426 | $9 |
| Ondansetron Odt | 16 | $423 | $26 |
| Nitrofurantoin Mono-Macro | 25 | $419 | $17 |
| Citalopram Hbr | 26 | $418 | $16 |
| Simvastatin | 41 | $400 | $10 |
| Amoxicillin-Clavulanate Potass | 39 | $381 | $10 |
| Sertraline | 32 | $375 | $12 |
| Metoprolol | 17 | $374 | $22 |
| Duloxetine | 15 | $360 | $24 |
| Cephalexin | 21 | $347 | $17 |
| Atenolol | 41 | $337 | $8 |
| Amitriptyline | 12 | $303 | $25 |
| Furosemide | 63 | $302 | $5 |
| Pravastatin | 18 | $296 | $16 |
| Allopurinol | 17 | $290 | $17 |
| Azithromycin | 40 | $284 | $7 |
| Temazepam | 39 | $244 | $6 |
| Famotidine | 31 | $244 | $8 |
| Fluoxetine | 17 | $231 | $14 |
| Lisinopril-Hydrochlorothiazide | 23 | $223 | $10 |
| Carvedilol | 28 | $215 | $8 |
| Finasteride | 27 | $209 | $8 |
| Glipizide | 35 | $208 | $6 |
| Carisoprodol | 11 | $199 | $18 |
| Montelukast | 17 | $192 | $11 |
| Baclofen | 11 | $187 | $17 |
| Tramadol | 40 | $187 | $5 |
| Methylprednisolone | 27 | $185 | $7 |
| Acyclovir | 12 | $173 | $14 |
| Hydrochlorothiazide | 50 | $169 | $3 |
| Glimepiride | 21 | $167 | $8 |
| Prednisone | 26 | $162 | $6 |
| Naproxen | 21 | $154 | $7 |
| Meclizine | 16 | $152 | $10 |
| Hydroxyzine | 12 | $142 | $12 |
| Hydralazine | 16 | $134 | $8 |
| Triamcinolone Acetonide | 12 | $132 | $11 |
| Alprazolam | 40 | $124 | $3 |
| Ciprofloxacin | 31 | $122 | $4 |
| Oxybutynin Chloride | 22 | $119 | $5 |
| Clonazepam | 27 | $116 | $4 |
| Sure Comfort | 11 | $110 | $10 |
| Tizanidine | 12 | $109 | $9 |
| Metformin Hcl Er | 13 | $102 | $8 |
| Ropinirole | 11 | $98 | $9 |
| Donepezil | 19 | $74 | $4 |
| Sulfamethoxazole-Trimethoprim | 17 | $73 | $4 |
| Fluconazole | 16 | $59 | $4 |
| Triamterene-Hydrochlorothiazid | 12 | $48 | $4 |
| Cyclobenzaprine | 16 | $48 | $3 |
| Metoclopramide | 12 | $48 | $4 |
| Amoxicillin | 16 | $47 | $3 |
| Clonidine | 15 | $33 | $2 |
| Diazepam | 13 | $28 | $2 |
2022: 27 drugs
| Albuterol Sulfate Hfa | 28 | $942 | $34 |
| Hydrocodone-Acetaminophen | 37 | $745 | $20 |
| Atorvastatin | 59 | $570 | $10 |
| Fluticasone Propionate | 23 | $526 | $23 |
| Levothyroxine | 29 | $476 | $16 |
| Nitrofurantoin Mono-Macro | 12 | $288 | $24 |
| Tamsulosin | 12 | $209 | $17 |
| Losartan | 30 | $208 | $7 |
| Tramadol | 16 | $192 | $12 |
| Lisinopril | 31 | $191 | $6 |
| Metformin | 27 | $175 | $6 |
| Amlodipine Besylate | 30 | $152 | $5 |
| Gabapentin | 12 | $150 | $12 |
| Omeprazole | 18 | $136 | $8 |
| Azithromycin | 18 | $133 | $7 |
| Ibuprofen | 25 | $117 | $5 |
| Temazepam | 15 | $112 | $7 |
| Metoprolol | 13 | $106 | $8 |
| Acyclovir | 13 | $93 | $7 |
| Alprazolam | 16 | $87 | $5 |
| Trazodone | 17 | $78 | $5 |
| Clonazepam | 16 | $74 | $5 |
| Zolpidem | 24 | $73 | $3 |
| Meloxicam | 21 | $62 | $3 |
| Simvastatin | 16 | $56 | $3 |
| Hydrochlorothiazide | 13 | $40 | $3 |
| Ciprofloxacin | 13 | $40 | $3 |
Money from drug and device companies
$30 in 2025
| 2025 | 2 | 2 | None | $30 |
| 2024 | 1 | 1 | None | $86 |
| 2023 | 3 | 4 | None | $70 |
| 2022 | 2 | 2 | None | $36 |
| 2021 | 2 | 2 | None | $39 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $16 | 1 payment
|
| Amgen | Otezla | $15 | 1 payment
|
See all 2 published payments
| Amgen | Meals · 2025-10-10 | Otezla | $15 |
| Exact Sciences | Meals · 2025-07-11 | Cologuard Collection Kit | $16 |
See earlier years (2024, 2023, 2022, 2021)
2024: $86
| Abiomed | Impella | $86 | 1 payment
|
2023: $70
| Exact Sciences | Cologuard Collection Kit | $34 | 2 payments
|
| Amgen | Otezla | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $15 | 1 payment
|
2022: $36
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
2021: $39
| AstraZeneca Pharmaceuticals LP | Breztri | $23 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $16 | 1 payment
|
Professional record
- NPI
- 1477126365
- Licence
- CA 95017827
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LG0600X (363LG0600X)
- Mailing address
- 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306
- NPI first listed
- 2021-07-20
- NPI last updated
- 2026-03-26
- NPI record certified
- 2026-03-26
This is when the NPI record was last certified, not a medical board exam.